🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nathan Handley

Thomas Jefferson University

ORCID: 0000-0001-5804-4784

Also affiliated with Sidney Kimmel Cancer Center

Economics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing”.

Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.106821

N/A

0.673DataRank · unranked

13 citations

Heather H. Cheng, Amy Leader, Laura Gross, Tatiana Sanchez Nolasco, Nataliya Byrne +21 more

Distress screening for patients with a history of cancer during the COVID-19 pandemic.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e13537

N/A

0DataRank · unranked

0 citations

Lauren Waldman, Gregory Garber, Subecha Dahal, Adam F. Binder, Valerie Pracilio Csik +6 more

Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer

Prostate Cancer and Prostatic Diseases(2023)10.1038/s41391-023-00762-3

N/A

0DataRank · unranked

4 citations

Rui Luo, William Kevin Kelly, Joshua Chen, Shane Donahue, Kevan Ip +12 more